Intra‐aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock
Referencias
Additional references
American Heart Association. Heart Disease and Stroke Statistics ‐ 2008 Update. Dallas, Texas: American Heart Association, 2008.
Arafa OE, Pedersen TH, Svennevig JL, Fosse E, Geiran OR. Vascular complications of the intraaortic balloon pump in patients undergoing open heart operations: 15‐year experience. Annals of Thoracic Surgery 1999;67:645‐51.
Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, et al. The use of intra‐aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: Data from the National Registry of Myocardial Infarction 2. American Heart Journal 2001;141(6):933‐9.
British Heart Foundation. Coronary Heart Disease Statistics. London: British Heart Foundation, 2007.
Field ML, Rengarajan A, Khan O, Spyt T, Richens D. Preoperative intra aortic balloon pumps in patients undergoing coronary bypass grafting. Cochrane Database of Systematic Reviews 2007, Issue 1. [DOI: 10.1002/14651858.CD004472.pub2]
Flaherty JT, Becker LC, Weiss JL, JA Brinker, BH Bulkley, G Gerstenblith, et al. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. Journal of the American College of Cardiology 1985;6:434‐46.
Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (first of two parts). New England Journal of Medicine 1976;295(24):1356‐62.
Forrester JS, Diamond G, Chatterjee K, Swan HJ. Medical therapy of acute myocardial infarction by application of hemodynamic subsets (second of two parts). New England Journal of Medicine 1976;295(25):1404‐13.
Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. New England Journal of Medicine 1999;340(15):1162‐9.
Green S, Higgins J, editors. Glossary. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. http://www.cochrane.org/resources/handbook/.
Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane‐handbook.org.
Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. New England Journal of Medicine 1999;341(9):625‐34.
Hochman JS, Sleeper LA, White HD, Dzavik V, Wong SC, Menon V, et al. One‐year survival following early revascularization for cardiogenic shock. JAMA 2001;285(2):190‐2.
Hochman JS. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 2003;107:2998‐3002.
Hochman 2007, Apolito R. The calm after the storm. Long‐term survival after cardiogenic shock. Journal of the American College of Cardiology 2007;50(18):1759‐60.
Hudson MP, Granger CB, Stebbins AL, et al. Cardiogenic shock survival and use of intraaortic balloon counterpulsation: results from the GUSTO I and III trials. Circulation 1999;100(Suppl):I370.
Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA 1968;203:135‐40.
Machin D, Stenning SP, Parmar MKB, Fayers PM, Girling DJ, Stephens RJ, et al. Thirty years of Medical Research Council randomized trials in solid tumours. Clinical Oncology 1997;9:100‐14.
Menon V, White H, LeJemtel T, Webb JG, Sleeper LA, Hochman JS. The clinical profile of patients with suspected cardiogenic shock due to predominant left ventricular failure: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries in cardiogenic shocK?. Journal of the American College of Cardiology 2000;36(3 Suppl A):1071‐6.
Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup D. Improving the quality of reports of meta‐analysis of randomized controlled trials: the QUOROM statement. Lancet 1999;354:1896‐1900.
Murray CJL, Lopez AD. Evidence‐based health policy ‐ Lessons from the global burden of disease study. Science 1996;274:740‐3.
O'Rourke MF, Norris RM, Campbell TJ, et al. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. American Journal of Cardiology 1981;47:815‐20.
Ohman EM, George BS, White CJ, Kern MJ, Gurbel PA, Freedman RJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction: results of a randomized trial. The Randomized IABP Study Group. Circulation 1994;90:792‐9.
Ohman EM, Hochmann JS. Aortic counterpulsation in acute myocardial infarction: Physiologically important but does the patient benefit?. American Heart Journal 2001;141:889‐92.
Ohman EM, Nanas J, Stomel RJ, Leesar MA, Nielsen DW, O'Dea D, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS trial. Journal of Thrombosis and Thrombolysis 2005;19(1):33‐9.
Parmar MKB, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17:2815‐34.
Piedbois P, Mondor H, Buyse M. Meta‐analyses based on abstracted data: A step in the right direction, but only a first step. Journal of Clinical Oncology 2004;22(19):3839‐41.
Riley RD, Simmonds MC, Look MP. Evidence combining individual patient data and aggregate data: a systematic review identified current practice and possible methods. Journal of Clinical Epidemiology 2007;60(5):431‐9.
Rogers WJ, Canto JG, Lambrew CT, Tiefenbrunn AJ, Kinkaid B, Shoultz DA, et al. Temporal trends in the treatment of over 1.5 million patients with myocardial infarction in the US from 1990 through 1999: the National Registry of Myocardial Infarction 1, 2 and 3. Journal of the American College of Cardiology 2000;36:2056‐63.
Ryan TJ, Anderson JL, Antman EM, Braniff BA, Brooks NH, Califf R M, et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction).. Journal of the American College of Cardiology 1999;28:1328‐1428.
Sanborn TA, Sleeper LA, Bates E, Jacobs AK, Boland J, French JK, et al. Impact of thrombolysis, intra‐aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. Journal of the American College of Cardiology 2000;36:1123‐9.
Santa‐Cruz RA, Cohen MG, Ohman EM. Aortic counterpulsation: A review of the hemodynamic effects and indications for use. Catheterization & Cardiovascular Interventions 2006;67(1):68‐77.
Stone GW, Marsalese D, Brodie B, Griffin JJ, Donohue B, Costantini C, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Journal of the American College of Cardiology 1997;29:1459‐67.
Whitehead N. Meta‐analysis of controlled clinical trials. Chichester: John Wiley & Sons, 2002.
Yusuf S, Hawken S, Ôunpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case‐control study. Lancet 2004;364:937‐52.
